JDSU--Stolen from JDSU thread
From CBS Marketwatch's picks of the week
Posted From: cbs.marketwatch.com.
LOS ANGELES (CBS.MW) - Individual investors rule. So believes Michael Witz, founder and chief executive of StockJungle.com, a money management Web site that tracks investment moves of its community's savviest individuals.
"There's been a fundamental shift in power from institutions to individuals," said Witz, 28. "Individuals have been given access to almost all of the same tools used by the professional community."
Witz should know. He's sat on both sides of the fence, first as a young investor and then as a securities analyst.
Fascinated by the stock market, Witz began investing at 16. With a few hundred dollars, he bought Zeos Computers for $1 a share after reading about its reorganization and PC awards. He sold at $13, before Micron (MUEI: news, msgs) bought the company.
Witz became an analyst for an investment bank, where he got the idea for StockJungle.com. Seeing online investment communities sprouting -- on Yahoo message boards among others -- he pondered how one can separate the best stock pickers from people just blowing smoke? Answer: By tracking their performance.
That's what StockJungle.com does, identifying the best regular Joe or Jane investors out of 14,000 people that use its site. The Web site then posts their stock picks to help other investors make money.
Last November, Witz created a no-load fund based on the people's best stock picks and evaluated by a team of money managers. Called the Community Intelligence Fund (SJCIX: news, msgs), it's a low-cost fund of large-cap growth stocks. As of July 26, it's up 31.4 percent, according to
Morningstar, a fund rating and securities analysis firm.
It's also the sixth best-performing large-cap growth fund this year out of 338 such funds, Morningstar reported.
For this week's stock picks, Witz scoured the StockJungle.com community for five favored stocks that are doing well.
Celera Genomics
Celera Genomics (CRA: news, msgs), a biotech unit of PE Corp. that has completed the mapping of the human genome, boasts 170 longs and nine shorts. A top community stock picker named "4site" bought Celera on Nov. 19 and has since seen a 321 percent gain on it. "Celera is a company that will have a genetic library in one year that may give the road map to drug discovery for the next twenty years," 4site claims. By mapping out DNA, Celera will help medical researchers develop drugs to combat diseases.
JDS Uniphase
Fiber-optic components maker JDS Uniphase (JDSU: news, msgs) has been making news lately with its planned acquisition of rival SDL (SDLI: news, msgs) and after joining the Standard & Poor's 500. It's the second-most popular pick, with 533 people long and 20 short. Investor "Eddieeagle" believes that "JDSU is #1 and will have earnings growth of at least 25 percent a year for the next three to five years. Tuck this jewel away in your portfolio and forget about it for three years." Many others echo his sentiments, Witz said. JDS makes components that allow the transmission of huge amounts of data over fiber-optics networks -- critical
in the Internet age. |
